Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial.

Autor: Oken MM, Hocking WG, Kvale PA, Andriole GL, Buys SS, Church TR, Crawford ED, Fouad MN, Isaacs C, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Ragard LR, Rathmell JM, Riley TL, Wright P, Caparaso N, Hu P, Izmirlian G

Publikováno v: JAMA: Journal of the American Medical Association; 11/2/2011, Vol. 306 Issue 17, p1865-1873, 9p

Factors Associated With Small Aggressive Non-Small Cell Lung Cancers in the National Lung Screening Trial: A Validation Study.

Autor: Warkentin MT; Department of Health Sciences, Brock University, St. Catharine's, Ontario, Canada.; Department of Cancer Epidemiology and Prevention Research, CancerControl Alberta, Alberta Health Services, Calgary, Alberta, Canada., Tammemägi MC; Department of Health Sciences, Brock University, St. Catharine's, Ontario, Canada., Freedman MT; Cancer Prevention and Control, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC., Ragard LR; Westat, Rockville, MD., Hocking WG; Department of Clinical Oncology, Marshfield Clinic Health System, Marshfield, WI., Kvale PA; Division of Pulmonary and Critical Care Medicine, Henry Ford Health System, Detroit, MI., Brenner DR; Department of Cancer Epidemiology and Prevention Research, CancerControl Alberta, Alberta Health Services, Calgary, Alberta, Canada.; Departments of Community Health Sciences and Oncology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada., Hu P; Biometry Research Group, National Cancer Institute, Bethesda, MD., Riley TL; Information Management Services, Inc., Rockville, MD., Commins J; Information Management Services, Inc., Rockville, MD., Church TR; Division of Environmental Health Sciences, School of Public Health, University of Minnesota, Minneapolis, MN., Berg CD; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD.

Publikováno v: JNCI cancer spectrum [JNCI Cancer Spectr] 2018 Jan 31; Vol. 2 (1), pp. pkx010. Date of Electronic Publication: 2018 Jan 31 (Print Publication: 2018).

Diagnostic evaluation following a positive lung screening chest radiograph in the Prostate, Lung, Colorectal, Ovarian (PLCO) Cancer Screening Trial.

Autor: Hocking WG; Department of Oncology/Hematology, Marshfield Clinic, Marshfield, WI, USA. Electronic address: hocking.william@marshfieldclinic.org., Tammemagi MC, Commins J, Oken MM, Kvale PA, Hu P, Ragard LR, Riley TL, Pinsky P, Beck TM, Prorok PC

Publikováno v: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2013 Nov; Vol. 82 (2), pp. 238-44. Date of Electronic Publication: 2013 Aug 07.

Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.

Autor: Buys SS; Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, USA., Partridge E, Black A, Johnson CC, Lamerato L, Isaacs C, Reding DJ, Greenlee RT, Yokochi LA, Kessel B, Crawford ED, Church TR, Andriole GL, Weissfeld JL, Fouad MN, Chia D, O'Brien B, Ragard LR, Clapp JD, Rathmell JM, Riley TL, Hartge P, Pinsky PF, Zhu CS, Izmirlian G, Kramer BS, Miller AB, Xu JL, Prorok PC, Gohagan JK, Berg CD

Publikováno v: JAMA [JAMA] 2011 Jun 08; Vol. 305 (22), pp. 2295-303.